Wealthfront Advisers
EXAS

Wealthfront Advisers’s Exact Sciences EXAS Stock Holding History

Wealthfront Advisers’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,680
Closed -$475K – 1091
2025
Q4 		$475K Sell
4,680
-59
-1% -$4.74K ﹤0.01% 828
2025
Q3 		$259K Sell
4,739
-266
-5% -$13.3K ﹤0.01% 929
2025
Q2 		$266K Sell
5,005
-241
-5% -$12.2K ﹤0.01% 891
2025
Q1 		$227K Sell
5,246
-136
-3% -$6.89K ﹤0.01% 888
2024
Q4 		$302K Sell
5,382
-118
-2% -$7.34K ﹤0.01% 835
2024
Q3 		$375K Sell
5,500
-89
-2% -$5.02K ﹤0.01% 803
2024
Q2 		$236K Sell
5,589
-2,195
-28% -$121K ﹤0.01% 829
2024
Q1 		$538K Sell
7,784
-172
-2% -$10.9K ﹤0.01% 725
2023
Q4 		$589K Sell
7,956
-104
-1% -$6.82K ﹤0.01% 682
2023
Q3 		$550K Sell
8,060
-196
-2% -$16.6K ﹤0.01% 670
2023
Q2 		$775K Sell
8,256
-136
-2% -$10.6K ﹤0.01% 605
2023
Q1 		$569K Sell
8,392
-333
-4% -$21.4K ﹤0.01% 634
2022
Q4 		$432K Buy
+8,725
New +$356K ﹤0.01% 662
2022
Q1 		– Sell
-6,145
Closed -$478K – 786
2021
Q4 		$478K Sell
6,145
-4,140
-40% -$365K ﹤0.01% 602
2021
Q3 		$982K Buy
+10,285
New +$1.09M ﹤0.01% 475

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Wealthfront Advisers's EXAS Position: Q1 2026 in Review

Wealthfront Advisers sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 4,680 shares — an estimated $475K sold.

Wealthfront Advisers first reported a position in EXAS in Q3 2021 and held it in 15 quarters. The position peaked at $982K in Q3 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Wealthfront Advisers reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Wealthfront Advisers sold 4,680 Exact Sciences shares in Q1 2026, an estimated $475K.
  • Wealthfront Advisers first reported a position in Exact Sciences in Q3 2021 and held it in 15 quarters.
  • Wealthfront Advisers's Exact Sciences position peaked at $982K in Q3 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Wealthfront Advisers's 13F filing for Q1 2026, filed 5 May 2026.